Company / Total Assets
Larimar Therapeutics, Inc. Total Assets History
FY2014-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$80.7M
FY2019
5-year range
$80.7M / $189.1M
FY2015-FY2019
Trend
-33.7%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has fluctuated over the past 6 years, ranging from $81M in FY2019 to $189M in FY2015.
Based on SEC 10-K filings.
$81M in FY2019 with a 5-year CAGR of -7.2%.
Declined from $106M to $81M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -15.0%
- 5-Year CAGR
- -7.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -7.2%, indicating a declining trend.
- In FY2019, total assets decreased 33.7% year-over-year.
- Peak total assets was recorded in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.64 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $80.7M | -33.7% |
| FY2018 | $121.8M | +15.4% |
| FY2017 | $105.5M | -19.8% |
| FY2016 | $131.6M | -30.4% |
| FY2015 | $189.1M | +60.9% |
| FY2014 | $117.5M | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026